camptothecin has been researched along with transferrin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, M; Jiang, Y; Pei, Y; Tang, G; Zhu, S | 1 |
| Fang, C; Hong, M; Jiang, Y; Pei, Y; Shi, B; Sun, C; Tang, G; Zhu, S | 1 |
| Furuse, J; Hosokawa, Y; Iwamoto, N; Kase, Y; Kitagawa, N; Miyazawa, T; Motoori, S; Saisho, H | 1 |
| Chen, J; Dong, J; Gu, W; Lu, S; Peng, P; Xiong, Z; Xu, F; Yang, X | 1 |
| Bi, Y; Lee, RJ; Li, C; Li, L; Sun, Y; Teng, L; Wang, M; Wang, X; Xie, J | 1 |
5 other study(ies) available for camptothecin and transferrin
| Article | Year |
|---|---|
Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
Topics: Animals; Antineoplastic Agents; Biological Availability; Camptothecin; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cyanoacrylates; Cytoplasm; Drug Delivery Systems; Endocytosis; Humans; K562 Cells; Liposomes; Male; Mice; Mice, Inbred Strains; Neoplasms; Particle Size; Polyethylene Glycols; Rats; Rats, Wistar; Sarcoma 180; Tissue Distribution; Transferrin | 2009 |
Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Chromatography, High Pressure Liquid; Drug Carriers; Drug Stability; Humans; Male; Mice; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyethylene Glycols; Rats; Sarcoma 180; Solubility; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tissue Distribution; Transferrin; Xenograft Model Antitumor Assays | 2010 |
[Two cases of colorectal cancer presenting with periodic, transient elevation of serum iron after chemotherapy including irinotecan].
Topics: Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Colorectal Neoplasms; Female; Humans; Irinotecan; Iron; Transferrin | 2010 |
Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cyclodextrins; Drug Carriers; Drug Delivery Systems; Drug Stability; Lactones; Liposomes; Mice; Mice, Inbred ICR; Neoplasms; Rats; Rats, Sprague-Dawley; Transferrin | 2015 |
Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy.
Topics: Animals; Apoptosis; Biological Transport; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Endocytosis; Female; Gene Silencing; Gene Transfer Techniques; HeLa Cells; Humans; Inhibitor of Apoptosis Proteins; Irinotecan; Liposomes; Mice, Nude; Neoplasms; Particle Size; Prodrugs; RNA, Small Interfering; Survivin; Tissue Distribution; Transferrin | 2018 |